Dow Eyes Fifth Straight Win in Volatile Session

Cisco earnings are helping the Dow keep its head above water

Feb 15, 2018 at 11:58 AM
facebook twitter linkedin


It's been a volatile day of trading on Wall Street following this morning's latest inflation update, with the Dow Jones Industrial Average (DJI) exploring a 311-point range on both sides of breakeven so far. At last check, the blue-chip index was in positive territory, and earlier traded north of 25,000 for the first time since Feb. 7, thanks to a positive earnings reaction for Cisco (CSCO) stock. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) have also erased earlier losses, with all three benchmarks pacing for a fifth straight gain -- the Dow's longest win streak of 2018, and the longest for the SPX and Nasdaq since early January.

Continue reading for more on today's market, including:

  • 2 pharma stocks on fire.
  • Drop this oil stock before the weekend.
  • Plus, Pandora targeted for a pre-earnings options play; a surging retail stock; and the cancer drug stock up 50%.

midday market stats feb 15

Among the stocks with unusual options volume today is Pandora Media Inc (NYSE:P), with nearly 27,000 calls on the tape -- 16 times the average intraday rate. By comparison, just 890 puts have traded. Almost all of the volume occurred when 20,000 weekly 2/23 5.50-strike calls were likely bought to open for $0.33 apiece, per Trade-Alert, likely betting on post-earnings upside after the streaming service reports next Wednesday night. P stock is up 1.4% today to trade at $4.97.

Build-A-Bear Workshop, Inc (NYSE:BBW) is one of the best stocks on the New York Stock Exchange (NYSE) so far today, after the toy retailer reported better-than-expected adjusted fourth-quarter profit. BBW was last seen up 15.4% at $9, but running out of steam near the site of a mid-January bear gap.

bbw stock daily chart feb 15

Moleculin Biotech Inc (NASDAQ:MBRX) is at the top of the Nasdaq, after the pre-clinical stage pharmaceutical firm said it's created and licensed a breakthrough molecular cancer treatment. The penny stock is up 55% to trade at $2.82 -- on track for its highest close since last June.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners